SDZ-62-434

CAS No. 115621-95-9

SDZ-62-434( —— )

Catalog No. M34417 CAS No. 115621-95-9

SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 445 Get Quote
5MG 686 Get Quote
10MG 938 Get Quote
25MG 1398 Get Quote
50MG 1822 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SDZ-62-434
  • Note
    Research use only, not for human use.
  • Brief Description
    SDZ-62-434, a platelet-activating factor inhibitor with antitumor activity, inhibits bombesin- and platelet-derived growth factor-induced DNA synthesis in quiescent Swiss 3T3 cells, making it a potential candidate for studying leukemia, human xenograft colorectal cancer, and lung cancer.
  • Description
    SDZ-62-434 is a platelet-activating factor (PAF) antagonist. SDZ-62-434 has antiproliferative activity in human solid and haematological malignancies.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Platelet aggregation
  • Recptor
    Platelet aggregation
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    115621-95-9
  • Formula Weight
    416.39
  • Molecular Formula
    C23H27Cl2N3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C12=NCCN1C(C3=CC=C(CN4CCCCC4)C=C3)=CC5=C2C=CC=C5.Cl.Cl
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. V G Brunton, et al. In vitro antitumour activity of the novel imidazoisoquinoline SDZ 62-434. Br J Cancer. 1993 May;67(5):989-95.?
molnova catalog
related products
  • Suloctidil

    Suloctidil is a new drug that is currently being evaluated in many clinical trials for use in dementia and thrombotic disorders.

  • Veratrosine

    Veratrosine is an alkaloid isolated from the herbs of Veratrum nigrum. Veratrosine exhibits feeble inhibition activity against platelet aggregation.

  • Carbasalate?Calcium

    Carbasalate calcium?is an?analgesic,?antipyretic, and?anti-inflammatory?drug,?as well as a?platelet aggregation inhibitor.?